[1]
Amir, S., Laique, F. and Azam, M.M. 2024. Unlocking hope: talquetamab in multiple myeloma treatment: a bispecific breakthrough targeting CD3 and GPRC5D. International Journal of Scientific Reports. 10, 6 (May 2024), 221–224. DOI:https://doi.org/10.18203/issn.2454-2156.IntJSciRep20241321.